Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | IFITM3 |
| Upstream (Parents) |
|---|
| (<<) ACTB → IFITM3 |
| (<<) CRK → IFITM3 |
| (<<) CYB5R3 → IFITM3 |
| (<<) GAPDH → IFITM3 |
| (<<) GLRX → IFITM3 |
| (<<) HLA-G → IFITM3 |
| (<<) HSPB1 → IFITM3 |
| (<<) ITGA5 → IFITM3 |
| (<<) KLF6 → IFITM3 |
| (<<) PTAFR → IFITM3 |
| (<<) PTPN11 → IFITM3 |
| (<<) RAC2 → IFITM3 |
| (<<) SHC1 → IFITM3 |
| (<<) STAT1 → IFITM3 |
| (<<) TAGLN2 → IFITM3 |
| (<<) THOC4 → IFITM3 |
| (<<) TSPAN3 → IFITM3 |
| (<<) UBE2L6 → IFITM3 |
| Downstream (Children) |
|---|
| IFITM3 → ARAF (>>) |
| IFITM3 → ASB1 (>>) |
| IFITM3 → CAPRIN2 (>>) |
| IFITM3 → DLX2 (>>) |
| IFITM3 → EIF2AK2 (>>) |
| IFITM3 → EPHB2 (>>) |
| IFITM3 → GSTK1 (>>) |
| IFITM3 → HDAC4 (>>) |
| IFITM3 → ICAM1 (>>) |
| IFITM3 → KLHDC5 (>>) |
| IFITM3 → LRP6 (>>) |
| IFITM3 → MSN (>>) |
| IFITM3 → PABPC3 (>>) |
| IFITM3 → PDK2 (>>) |
| IFITM3 → PTGER1 (>>) |
| IFITM3 → RASD1 (>>) |
| IFITM3 → SH3TC1 (>>) |
| IFITM3 → SOCS6 (>>) |
| IFITM3 → SULT1A1 (>>) |
| IFITM3 → SUMF1 (>>) |
| IFITM3 → TINF2 (>>) |
